Atlas Trials

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Clinical trial NCT01484977 · COMPLETED

Trial details

NCT number
NCT01484977
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsy
Start date
2011-12-01
Primary completion
2013-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.